Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/31/2025

Control of Involuntary Movements

Characteristics of Movements in PKD

  • Some patients with Paroxysmal Kinesigenic Dyskinesia (PKD) can attenuate dyskinetic attacks by slowing down their movements when experiencing an aura, which occurs in approximately 78-82% of cases 1, 2
  • The aura is described as abnormal sensations (numbness, tingling, muscle weakness) that precede involuntary movements 1, 3
  • This capacity for voluntary modification is specific to PKD and does not apply to most other forms of chorea 1
  • Attacks include dystonia, chorea, ballism, or combinations of these, with dystonia being the most common form 2, 3
  • The duration of attacks is less than 1 minute in more than 98% of patients 2, 3
  • Movements are triggered by sudden voluntary actions (standing up, starting to run) 2, 4

Discinesia Tardia

  • Up to 50% of young people receiving neuroleptics may experience some form of tardive dyskinesia or withdrawal 5, 6

Differentiation Between Conditions

  • It is critical not to confuse the limited ability of some patients with PKD to modify their attacks through movement slowing with tardive dyskinesia, where there is no possible voluntary control 1, 3

Implications for Management

  • For tardive dyskinesia, the therapeutic approach should focus on pharmacological treatment (VMAT2 inhibitors such as valbenazine or deutetrabenazine) or discontinuation of the causative agent, not on voluntary control techniques 5
  • For PKD, in addition to pharmacological treatment with sodium channel blockers (carbamazepine 50-200 mg/day), some patients may benefit from recognizing the aura and modifying their movements 7